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BACKGROUND. Reports from limited geographic regions indicate higher rates of
cervical cancer incidence in American Indian and Alaska Native (AI/AN) women
than in women of other races. However, accurate determinations of cervical can-
cer incidence in AI/AN women have been hampered by racial misclassification in
central cancer registries.
METHODS. The authors linked data from cancer registries participating in the
National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiol-
ogy, and End Results (SEER) Program with Indian Health Service (IHS) enroll-
ment records to improve identification of AI/AN race. NPCR and SEER data were
combined to estimate annualized age-adjusted rates (expressed per 100,000 per-
sons) for the diagnosis years 1999 to 2004. Analyses focused on counties known
to have less racial misclassification, and results were stratified by IHS Region.
Approximately 56% of AI/ANs in the US reside in these counties. The authors
examined overall and age-specific incidence rates and stage at diagnosis for AI/
AN women compared with non-Hispanic white (NHW) women.
RESULTS. Invasive cervical cancer incidence rates among AI/AN women varied
nearly 2-fold across IHS regions, with the highest rates reported in the Southern
Plains (14.1) and Northern Plains (12.5); the lowest rates were in the Eastern region
and the Pacific Coast. Overall, AI/ANwomen had higher rates of cervical cancer than
NHWwomen andweremore likely to be diagnosed with later stage disease.
CONCLUSIONS. The wide regional variation of invasive cervical cancer incidence
indicates an important need for health services research regarding cervical cancer
screening and prevention education as well as policy development regarding
human papillomavirus vaccine use, particularly in the regions with high inci-
dence rates. Cancer 2008;113(5 suppl):1234–43. Published 2008 by the American
Cancer Society.*
KEYWORDS: American Indian/Alaska Native, cervical cancer, surveillance, inci-
dence.
F or all cancer sites combined, the majority of American Indianand Alaska Native (AI/AN) populations have exhibited rates
lower than or similar to those of non-Hispanic white (NHW) popu-
lations or members of all racial groups combined.1-4 However, for
cervical cancer and for preinvasive cervical lesions, prior investiga-
tions have found AI/AN women to have higher rates than other
populations.1,5-9 Furthermore, the majority of data regarding cervical
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cancer mortality in AI/AN women published to date
demonstrated substantially higher rates in compari-
son to NHW women.5,8,10,11 This discrepancy has
been most dramatically demonstrated among AI/AN
women in the Southwest compared with other popu-
lations in the Southwest, through data collected by
the New Mexico Tumor Registry, a long-standing Sur-
veillance, Epidemiology, and End Results (SEER) site
that operates with a minimum of racial misclassifica-
tion.5,6,12 Although rates for invasive cervical cancer in
AI/AN women in New Mexico and Alaska have been
declining in recent years,13,14 rates for preinvasive
lesions have remained high in some groups.5,9,15-17
Despite studies from limited geographic regions,
AI/AN women have often been excluded from national
and state reporting on cervical cancer because of race
misclassification in central cancer registries.18-21 The
purpose of the current study was to improve our char-
acterization of invasive cervical cancer incidence and
stage at diagnosis in AI/AN women relative to NHW
women, using techniques to minimize the effect of
racemisclassification in cancer surveillance data.
MATERIALS AND METHODS
Detailed descriptions of the data sources and meth-
ods used for this analysis are found in another article
in this supplement.22
Cancer Cases
US state and regional population-based cancer regis-
tries collect information on new cancer diagnoses.23
They participate in the National Program of Cancer
Registries (NPCR) of the Centers for Disease Control
and Prevention (CDC), the SEER Program of the
National Cancer Institute (NCI), or both.24 Primary
cancer site and histology data are coded according to
the International Classification of Diseases for Oncol-
ogy (ICD-O) edition in use at the time of diagnosis
and converted to the third edition.25 For this study,
cervical cancer incidence data generally refer to in-
vasive cancers (ICD-O-3 C530-C539); lymphomas
originating in the lymphatic tissue of the cervix,
other histologies involving hematopoietic diseases,
mesotheliomas, and Kaposi sarcomas were excluded
(M9590-9989, 9050-9055, 9140). We did not examine
in situ cervical tumors, which have not been reporta-
ble to NPCR and SEER since 1996. All cervical cancer
data included in this study have been reviewed by
cancer registrars, and meet the US Cancer Statistics
standards24; the states that met quality criteria and
that are included in the analysis are listed in the
footnotes of Table 1.
Coding race for AI/AN cancer cases in this report
combines information from 2 sources: 1) data lin-
kages with the Indian Health Service (IHS) patient
registration database, developed because the IHS
TABLE 1
Cervical Cancer Incidence by Indian Health Service Region for American Indians/Alaska Nativesa and Non-Hispanic Whites, US, 1999 to 2004
IHS Region
CHSDA Counties All Counties
AI/AN
Count
AI/AN
Rateb
95% CI for
AI/AN Rate
NHW
Rateb
Rate Ratioc
(AI/AN:NHW)
95% CI for
Rate Ratio
AI/AN
Count
AI/AN
Rateb
95% CI for
AI/AN Rate
NHW
Rateb
Rate Ratioc
(AI/AN:NHW)
95% CI for
Rate Ratio
Northern Plains 69 12.5 9.6-16.1 7.4 1.69d 1.29-2.18 97 9.7 7.7-12.0 7.6 1.28d 1.02-1.58
Alaskae 21 8.4 5.1-13.2 6.2 1.37 0.77-2.29 21 8.4 5.1-13.2 6.2 1.37 0.77-2.29
Southern Plains 117 14.1 11.6-16.9 9.1 1.54d 1.25-1.87 136 11.1 9.3-13.2 8.6 1.30d 1.08-1.54
Pacific Coast 65 6.9 5.2-8.9 7.0 0.98 0.74-1.27 85 4.9 3.9-6.1 7.0 0.70d 0.55-0.88
East 15 7.1 3.9-11.8 7.3 0.97 0.53-1.62 63 4.0 3.0-5.2 8.0 0.50d 0.38-0.65
Southwest 94 7.8 6.2-9.6 7.3 1.07 0.85-1.32 100 7.3 5.9-8.9 6.8 1.08 0.86-1.32
Total 381 9.4 8.5-10.4 7.4 1.28d 1.15-1.42 502 6.9 6.3-7.6 7.7 0.90d 0.82-0.99
Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries (NPCR) and/or the National Cancer Institute’s Surveillance, Epidemiology and End Results
(SEER) program.
CHSDA indicates Contract Health Service Delivery Areas; IHS, Indian Health Service; AI/AN, American Indians/Alaska Natives; 95% CI, 95% confidence interval; NHW, non-Hispanic whites.
a AI/AN race is reported by NPCR and SEER registries or through linkage with the IHS patient registration database. AI/AN persons of Hispanic origin are included.
b Rates are per 100,000 persons and are age-adjusted to the 2000 US standard population (19 age groups).
c Rate ratios are calculated in SEERaStat prior to rounding of rates and may not equal rate ratios calculated from rates presented in the table.
d Rate ratio is statistically significant (P < .05).
e Rates and rate ratios for Alaska in the CHSDA counties section is the same as those in the All Counties section because all counties in Alaska are CHSDA counties.
Years of data and registries used: 1999 to 2004 (41 states and the District of Columbia; *indicates states with at least 1 county designated as CHSDA): Alaska,* Alabama,* Arkansas, Arizona,* California,* Colo-
rado,* Connecticut,* District of Columbia, Delaware, Florida,* Georgia, Hawaii, Iowa,* Idaho,* Illinois, Indiana,* Kentucky,* Louisiana,* Massachusetts,* Maine,* Michigan,* Minnesota,* Missouri, Montana,* North
Carolina,* Nebraska,* New Hampshire, New Jersey, New Mexico,* Nevada,* New York,* Ohio, Oklahoma,* Oregon,* Pennsylvania,* Rhode Island,* Texas,* Utah,* Washington,* Wisconsin,* West Virginia, and
Wyoming*; 1999 and 2002 to 2004: North Dakota*; 2001 to 2004: South Dakota*; 2003 to 2004: Mississippi* and Virginia; 2004: Tennessee.
Percent regional coverage of AI/AN in CHSDA counties to AI/AN in all counties: Alaska: 100%; East: 13.1%; Northern Plains: 59.0%; Southern Plains: 64.1%; Pacific Coast: 55.6%; Southwest: 87.5.1%.
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provides medical services to AI/AN persons who are
members of federally recognized tribes; and 2) the
multiple race fields in central cancer registry
records.26 To reduce the misclassification of AI/AN
race, all case records from each state were linked
with the IHS patient registration database to identify
AI/AN cases misclassified as another race. Linkages
were conducted using LinkPlus, a probabilistic link-
age software program developed by the CDC that
was applied to key patient identifiers (social security
number, first name, last name, middle initial, date
of birth, and date of death).27 Possible matches,
requiring manual review, were examined independ-
ently by 2 reviewers, and when necessary, adjudicated
by a third reviewer. The information from the linkages
was then combined with the multiple race fields coded
in cancer registry records. Further details regarding
the linkage and coding rules for multiple races are
described elsewhere in this supplement.22
Contract Health Service Delivery Area (CHSDA)
counties and IHS regions were geographic factors
used to characterize further the burden of cancer
incidence in the AI/AN population. CHSDA counties,
in general, contain federally recognized tribal lands
or are adjacent to tribal lands. The proportions of
AI/AN persons in relation to total population are
higher in CHSDA counties than in non-CHSDA coun-
ties, and CHSDA counties demonstrate less race mis-
classification for AI/ANs.28 Data are presented for
CHSDA counties and for all counties; however,
because the information is believed to be more accu-
rate for AI/AN persons living in CHSDA counties, the
focus of the analyses is on AI/AN residing in CHSDA
counties. The analysis of AI/AN data by IHS region
(Alaska, Pacific Coast, Northern Plains, Southern
Plains, Southwest, and East) conforms with known
regional patterns of specific health outcomes and
disease risk factors for AI/AN.11,29 A map depicting
the IHS regions and indicating states and CHSDA
counties included in the analysis is presented in Fig-
ure 1. Approximately 56% of the US AI/AN population
reside in CHSDA counties. This proportion varies by
IHS region, from 15.4% reported in the East to 100% in
Alaska. Additional details regarding CHSDA counties
and IHS regions are provided elsewhere.22
Disease stage data for this report spanned
changes in SEER summary stage coding. Stage was
coded according to SEER summary stage 1977 rules
for diagnosis years 1999 to 2000 and to SEER sum-
mary stage 2000 rules for 2001 to 2003; collaborative
stage data, first reported for 2004, were not available
for analysis. Because the 2 staging systems are com-
parable for cervical cancer,30,31 we combined 1999 to
2003 data in the stage analysis.
Population Estimates
Using population estimates from the Census Bureau
and the CDC’s National Center for Health Statistics,32
the NCI makes additional refinements regarding race
and county geographic codes; these estimates were
used as denominators in this report.22,33
Statistical Analyses
Two sets of statistics are provided for AI/AN and
NHW women: 1) data from all counties in 46 states
and the District of Columbia (referred to as ‘All
Counties’), and 2) data from counties designated as
CHSDA. In addition, All Counties data and CHSDA
counties data are provided for each IHS region. The
results described in the text refer to persons who re-
side in CHSDA counties unless otherwise noted.
Additional information concerning cases and popula-
tion coverage is available elsewhere in this supple-
ment.22
For all AI/AN and NHW populations, cancer inci-
dence rates were expressed per 100,000 persons and
were age-adjusted by 19 age groups (<1 year, 1-4, 5-
9, . . . , 80-84, and 851 years) to the 2000 US standard
population. Percent distributions for stage of disease
at diagnosis are also age-adjusted. For all analyses,
exact counts were suppressed when the category of
interest contained 5 cases. The age groups for the
cervical cancer analysis (15-29, 30-49, 50-64, and
651 years) were selected with consideration of
screening recommendations and other age-related
influences on screening and prevention, such as
Medicare benefits for those aged 65 years.
Using the age-adjusted incidence rates, standar-
dized rate ratios (RRs) were calculated for AI/AN
women using NHW rates for comparison. Confidence
FIGURE 1. States and Contract Health Service Delivery Areas (CHSDA)
counties by Indian Health Service region.
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intervals for age-adjusted rates and standardized RRs
were calculated based on methods described by
Tiwari et al34 using SEER*Stat 6.3.6 statistical soft-
ware.35
RESULTS
Our most important findings are summarized in
Tables 1 through 3. Table 1 demonstrates regional
variations in invasive cervical cancer incidence rates,
per 100,000 population, for AI/AN women that are
more striking than the variation among NHW
women. For the period 1999 through 2004 for AI/AN
women residing in CHSDA counties, invasive cervical
cancer incidence rates ranged from 14.1 in the
Southern Plains to 6.9 in the Pacific Coast region.
The rate for AI/AN women in the Northern Plains
was also elevated (12.5) in comparison with other
regions. For all regions combined, the incidence rate
was 9.4, which was significantly higher than the rate
for NHW women (7.4; RR of 1.28). Rates for AI/AN
females in All Counties were substantially lower than
those in CHSDA counties and will not be presented
for subsequent tables.
The age-specific rates for invasive cervical cancer
changed most notably for AI/AN women from their
30s and 40s, remained elevated through 64 years of
age, and were highest for women aged 65 years
(Table 2). This trend was consistent for most geo-
graphic areas nationwide. The mean age at diagnosis
for AI/AN women was 47.3 years versus 50.1 years
for NHW women (data not shown). The differences
in incidence rates for invasive cervical cancer
between AI/AN women and NHW women in CHSDA
counties increased with age. For AI/AN women aged
65 years, rates were 85% higher than for NHW
women. Rates for AI/AN women were highest in the
oldest age group, in contrast to NHW women, who
demonstrated the highest rates among women ages
30 to 49 years. For those women ages 30 years to
TABLE 2
Invasive Cervical Cancer Incidence Ratesa by Age and Indian Health Service Region for American Indians/Alaska Natives and Non-Hispanic
Whites, CHSDA Counties, US, 1999 to 2004
IHS Region
15-29 Years 30-49 Years 50-64 Years 651 Years
Count
Cases,
%a Rateb
95%
CI Count
Cases,
%a Rateb
95%
CI Count
Cases,
%a Rateb
95%
CI Count
Cases,
%a Rateb
95%
CI
American Indian/Alaska Native
Northern Plains 10 14.5 3.0 1.4-5.6 34 49.3 9.0 6.2-12.6 15 21.7 10.1 5.6-16.6 10 14.5 14.2c 6.6-26.9
Alaska d 9.5 1.5 0.2-5.3 13 61.9 7.3 3.9-12.6 d 14.3 4.1 0.8-12.1 d 14.3 9.7 2.0-27.9
Southern Plains d 3.4 0.9 0.3-2.3 75 64.1 14.7c 11.6-18.5 25 21.4 10.4 6.7-15.4 13 11.1 9.1 4.8-15.6
Pacific Coast 7 10.8 1.2 0.5-2.6 35 53.8 5.3 3.7-7.4 14 21.5 4.9 2.7-8.3 9 13.8 7.7 3.5-14.9
East d 13.3 1.8 0.2-6.3 6 40.0 3.9 1.4-8.4 d 26.7 6.2 1.7-15.8 d 20.0 10.2 2.1-29.7
Southwest 7 7.4 0.9 0.4-1.9 45 47.9 5.4 3.9-7.3 23 24.5 6.9 4.4-10.4 19 20.2 10.7c 6.4-16.8
Total 32 8.4 1.4 0.9-1.9 208 54.6 7.6c 6.6-8.8 84 22.0 7.4 5.9-9.2 57 15.0 10.0c 7.6-13.0
Non-Hispanic white
Northern Plains 154 8.7 1.8 1.5-2.1 850 47.9 6.3 5.9-6.7 435 24.5 5.7 5.1-6.2 336 18.9 5.1 4.6-5.7
Alaska d 3.8 0.6 0.1-1.7 46 59.0 4.9 3.6-6.6 21 26.9 4.9 3.0-7.5 8 10.3 5.2 2.2-10.4
Southern Plains 58 7.1 1.7 1.3-2.3 386 47.1 8.1 7.4-9.0 191 23.3 6.4 5.6-7.4 184 22.5 7.0 6.1-8.1
Pacific Coast 213 6.9 1.4 1.2-1.6 1583 51.2 6.4 6.0-6.7 738 23.9 5.1 4.7-5.4 556 18.0 4.7 4.3-5.1
East 106 4.8 1.2 1.0-1.4 961 43.5 6.0 5.6-6.3 577 26.1 6.1 5.6-6.6 566 25.6 6.4 5.8-6.9
Southwest 78 5.6 1.2 0.9-1.5 627 44.8 6.1 5.7-6.6 401 28.6 6.2 5.6-6.9 294 21.0 5.2 4.6-5.8
Total 612 6.5 1.4 1.3-1.5 4453 47.5 6.3 6.1-6.5 2363 25.2 5.7 5.5-5.9 1944 20.7 5.4 5.2-5.7
Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries (NPCR) and/or the National Cancer Institute’s Surveillance, Epidemiology and End Results
(SEER) program.
CHSDA indicates Contract Health Service Delivery Areas; IHS, Indian Health Service; 95% CI, 95% confidence interval.
a Percentages may not add up to 100.0% due to rounding.
b Rates are per 100,000 persons and are age-adjusted to the 2000 US standard population (19 age groups).
c The American Indian/Alaska Native rate is statistically significantly higher than the Non-Hispanic white rate (P < .05).
d Counts <6 are suppressed; if no cases were reported, then row percentages and rates could not be calculated.
Years of data and registries used: 1999 to 2004 (41 states and the District of Columbia; *indicates states with at least 1 county designated as CHSDA): Alaska,* Alabama,* Arkansas, Arizona,* California,* Colo-
rado,* Connecticut,* District of Columbia, Delaware, Florida,* Georgia, Hawaii, Iowa,* Idaho,* Illinois, Indiana,* Kentucky,* Louisiana,* Massachusetts,* Maine,* Michigan,* Minnesota,* Missouri, Montana,* North
Carolina,* Nebraska,* New Hampshire, New Jersey, New Mexico,* Nevada,* New York,* Ohio, Oklahoma,* Oregon,* Pennsylvania,* Rhode Island,* Texas,* Utah,* Washington,* Wisconsin,* West Virginia, and
Wyoming*; 1999 and 2002 to 2004: North Dakota*; 2001 to 2004: South Dakota*; 2003 to 2004: Mississippi* and Virginia; 2004: Tennessee.
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49 years, Southern Plains AI/AN women had the
highest rates for all the regions, but for AI/AN
women in the oldest age group, Northern Plains
women had the highest rates.
Stage of disease at diagnosis is shown in Table 3
for AI/AN and NHW women in CHSDA counties.
Herein, we noted a lower rate and proportion of
lesions diagnosed at the local stage (confined to the
cervix) among AI/AN women compared with NHW
women, and higher rates for regional and distant
stage cervical cancer among AI/AN women com-
pared with NHW women, for all regions combined.
Although specific regions of the country demon-
strated some variability with respect to stage at diag-
nosis, the majority of the findings were consistent
with the All-Regions pattern and generally demon-
strated lower rates and proportions of early invasive
cancer for AI/AN women.
DISCUSSION
Our results demonstrated regional differences in inci-
dence rates of invasive cervical cancer in AI/AN
women, with women in the Northern and Southern
Plains having the highest rates of the disease.
Furthermore, the rates comparing AI/AN with NHW
women were approximately 70% and 55% greater in
the Northern and Southern Plains regions, respec-
tively. Although rates of cervical cancer among AI/
AN women vary by region and remain overall higher
than in NHW women, in New Mexico and Alaska
(the only regions of the US with substantial AI/AN
populations in which analyses examining long-term
incidence trends have been possible), rates have
decreased substantially since the 1970s.5,13,14
Studies in non-AI/AN populations have demon-
strated that >50% of incident cervical cancer cases
can be attributed to no screening and another 10%
to no recent screening.36,37 Rates of invasive cervical
cancer in AI/AN women are currently lower than ear-
lier published reports; the decrease in rates can be
attributed, in part, to aggressive screening programs
that have been put into place in numerous clinics
that serve AI/AN women nationwide. The IHS-
initiated cervical cancer screening in the 1960s and
1970s resulted in declining cervical cancer incidence
and mortality rates in the 1980s and 1990s.5,13,14
With the establishment of the CDC’s National Breast
and Cervical Cancer Early Detection Program
(NBCCEDP), additional resources became available
to increase screening in AI/AN women.38 Programs
in all 50 states and 14 tribes (Arctic Slope Native
Association Limited, Barrow, Alaska; Cherokee
Nation, Tahlequah, Oklahoma; Cheyenne River Sioux
Tribe, Eagle Butte, South Dakota; Hopi Tribe, Kykots-
movi, Arizona; Kaw Nation of Oklahoma, Newkirk,
Oklahoma; Mississippi Band of Choctaw Indians,
Choctaw, Mississippi; Native American Rehabilitation
Association of the Northwest, Portland, Oregon; Nav-
ajo Nation, Window Rock, Arizona; Poarch Band of
Creek Indians, Atmore, Alabama; South East Alaska
Regional Health Consortium, Sitka, Alaska; South
Puget Intertribal Planning Agency, Shelton, Washing-
ton; Southcentral Foundation, Anchorage, Alaska;
and Yukon-Kuskokwim Health Corporation, Bethel,
Alaska) currently receive support from this program
to build infrastructure and provide screening ser-
vices. The prevalence of Papanicolaou (Pap) screen-
ing in all counties and all regions combined for the
period 1999 through 2006 based on Behavioral Risk
Factor Surveillance data as reported elsewhere in this
supplement39 remains slightly lower for AI/AN
women than for NHW women (78% vs 84%, respec-
tively). Regional prevalence estimates of Pap utiliza-
tion only loosely reflect regional incidence rates;
however, the observation that the Southern Plains
region has the highest incidence rate of cervical can-
cer and the lowest attendance for Pap screening39
indicates that screening prevalence influences re-
gional patterns of cervical cancer incidence in AI/AN
women.
During a site visit to the Navajo Reservation in
1989, the American College of Obstetricians and
Gynecologists’ Committee on American Indian
Affairs identified access to colposcopy, a part of the
standard diagnostic follow-up for abnormal Pap test
results, as an important unmet need. In response,
the CDC began supporting the IHS to conduct colpo-
scopy training, annual training for primary care pro-
viders to increase the availability of this service and
to reduce the time interval from abnormal screening
results to definitive diagnosis.40,41 Since then, the
IHS has increased the availability of colposcopy
nationwide by training IHS and tribal providers. The
IHS program provides basic colposcopy training with
a didactic course followed by a hands-on preceptor-
ship. In addition, annual review workshops and bien-
nial colposcopy update courses enhance the skills of
new and experienced colposcopists caring for AI/AN
women. As of 2007, this training has reached 284
physicians and advanced practice clinicians (certified
nurse midwives, nurse practitioners, and physician
assistants) from 105 IHS, tribal, and urban Indian
hospitals and clinics nationwide (unpublished data).
Continued diligence in education, training, and pre-
vention services is essential to further reduce the
death rate from cervical cancer. Clinicians and public
health practitioners, including those involved in the
1238 CANCER Supplement September 1, 2008 / Volume 113 / Number 5
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NBCCEDP, deserve much praise for their roles in
lowering rates of cervical cancer, and the compara-
tively low rates among AI/AN women now should be
viewed as a public health achievement of substantial
magnitude.
Despite the progress in reducing overall cervical
cancer rates, the higher overall rates in AI/AN
women and the unfavorable profile of local versus
advanced stage of disease at diagnosis indicate a
continued need for aggressive and comprehensive
screening and timely follow-up of abnormal results.
In addition to continued education and vigilance
related to screening, AI/AN women should be
made aware of the signs of cervical cancer (bleeding,
especially after intercourse) and the critical impor-
tance of seeking immediate care if that clinical sign
is apparent. Furthermore, it is critical to support
screening programs with capacity to provide timely
follow-up care for women with abnormal Pap
smears.
Previous research in other populations has docu-
mented an increased risk of cervical cancer or of pre-
invasive cervical lesions among women of lower
socioeconomic status.42,43 In 1 study among women
in the Southwest, AI/AN women with less than a
high school education and low annual income were
found to be at an increased risk of developing cervi-
cal intraepithelial neoplasia (CIN).16 In a similarly
designed study of risk factors for CIN among New
Mexico Hispanics and NHWs, Becker et al44 also
found strong risks associated with low economic sta-
tus and education levels. Brinton and Fraumeni
reported an inverse relation between socioeconomic
indicators of income and education and risk of inva-
sive cervical neoplasia for both black and white
women.45 For the period 2000 through 2006, poverty
among the AI/AN population nationally was 3 times
that of the NHW population, with the highest re-
gional prevalence of poverty noted in AI/ANs in the
Southwest.4 Furthermore, AI/AN adults were less
likely to have graduated from high school and were
more likely to have less than a ninth grade education
than NHW adults, with the Southwest and East AI/
AN populations experiencing the highest prevalence
of not finishing high school.4 Economic conditions in
the Plains states are also very unfavorable for AI/AN
people, compared with the NHW population.
Nonetheless, from an etiologic standpoint, pov-
erty and low levels of education are not the direct
cause of abnormal cervical epithelium, but only a
correlate of other factors, the most of important of
which is infection with oncogenic subtypes of human
papillomavirus (HPV). Finally, cigarette smoking
increases the risk for cervical neoplasia.46 Because
AI/AN women have a much higher prevalence of cig-
arette smoking, especially in the Plains region and
Alaska,39 addressing this important risk factor is criti-
cal to control a host of adverse health outcomes,
including cervical cancer.
The data from the current study generally de-
monstrated higher age-specific cervical cancer rates
for AI/AN women compared with NHW women, for
most regions of the country and for most age cate-
gories that we examined. However, racial differences
in rates were much less pronounced for the youngest
age group of women. In some regions, for certain
age groups, rates for NHW women exceeded rates for
AI/AN women (see Table 3), although this observa-
tion is the exception and may reflect the instability
of the AI/AN rates because of relatively small num-
bers of cases. The current study data do not allow us
to identify those factors that explain the higher rates
for NHW women than for AI/AN women in certain
regions.
Our analysis indicated that AI/AN women are
more commonly diagnosed with cervical cancer at a
later stage than NHW women. Many factors influ-
ence the stage at which cervical cancer is diagnosed,
and AI/AN women face several barriers to the early
detection of cervical dysplasia and invasive cancer.
Provider time pressures, health systems designed pri-
marily for acute and episodic care, and an under-
funded health system are potential barriers IHS and
tribal providers may face. In addition, cultural reluc-
tance to access Western medicine for nonacute
health problems and transportation difficulties are
factors commonly cited as barriers to cancer screen-
ing by AI/AN individuals.47-50
Although 2 HPV vaccines designed to prevent
cervical neoplasia are being tested, only 1, the quad-
rivalent vaccine, is now licensed in the US and
recommended for use among females ages 9 years to
26 years. In some parts of the country, health admin-
istrators are aggressively promoting vaccine uptake
among AI/AN patients (unpublished data). The Vac-
cines for Children Program (VFC) is a federal entitle-
ment program allowing private and public providers
who participate in the VFC program to vaccinate eli-
gible children with federally purchased vaccines as
approved by the CDC’s Advisory Committee on Im-
munization Practices. Children aged 19 years who
are Medicaid eligible, uninsured, AI/AN (as defined
by the Indian Health Services Act), are eligible to
receive vaccine from providers through the VFC pro-
gram.51 We will not have adequate information to
determine whether the vaccine will reduce cervical
cancer rates for many years, in AI/AN (or other)
populations, but the vaccine could have a more
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immediate impact on the incidence of abnormal cy-
tology, the number of follow-up procedures, and cer-
vical dysplasia.
As HPV vaccine development expands to include
other HPV types that cause cervical neoplasia,
greater reductions in preinvasive lesions can be
expected. Monitoring the HPV types infecting AI/AN
women will help determine whether vaccination or
newer technologies in screening are having an
impact. In collaboration with the New Mexico
Department of Health, investigators in New Mexico
have developed a statewide Pap smear registry. Link-
age of this registry to the New Mexico statewide im-
munization information system and, eventually, to
the New Mexico Tumor Registry will be important to
determining the efficacy, effectiveness, and safety of
the HPV vaccine. The support and partnership of
tribes and participation of AI/AN women will be cru-
cial to evaluate the cervical cancer control efforts in
that state (unpublished data). Researchers in Alaska
plan an array of activities focusing on implementing
and monitoring the HPV vaccine in AI/AN women.
These include educating the public regarding the
vaccine, monitoring vaccination coverage, measuring
the impact on rates of dysplasia and cancer, evaluat-
ing antibody duration, studying the HPV types found
in women undergoing colposcopy, and determining
the economic impact of the vaccine (unpublished
data).
There are several important limitations to our
analyses to consider when interpreting these results.
These include incidence rates based on small case
numbers, particularly when data are presented by
region and age group. Although data on screening
prevalence for AI/AN women reported by Steele et al
are presented elsewhere in this supplement,39 we do
not know the patterns of adequate follow-up or the
distribution of oncogenic HPV subtypes that may
determine differences in cervical cancer between AI/
AN and NHW women. Furthermore, we do not know
the proportion of AI/AN women or NHW women
who have undergone hysterectomies and are no lon-
ger at risk for cervical disease.
Previous studies have shown that many AI/AN
were misclassified as another race in cancer registry
data and that the extent of misclassification varied
by registry.18-21 Although linkages between cancer
registry data and the IHS patient registration data-
base improve the race classification for AI/AN cases,
AI/AN persons who are not members of the federally
recognized tribes, live primarily in urban settings,
live long distances from IHS facilities, live in counties
other than those designated as CHSDA, or are not el-
igible for IHS services are under-represented in the
IHS database. Additional details regarding the mis-
classification of AI/AN race are available elsewhere
in this supplement.16
Because we restricted the majority of the analy-
ses to CHSDA counties, in which only 56% of AI/AN
live and which tend to be located in more rural areas
and Western states (Fig. 1), the results should not be
generalized to all AI/AN (or NHW) women in the US.
In addition, the percentage of the AI/AN population
residing in CHSDA counties varies greatly among the
6 IHS regions. The percentage is particularly low in
the East region (15%).
In summary, the results of the current study
indicate a much improved picture of reduced inci-
dence of invasive cervical cancer in AI/AN women.
Nonetheless, the rates in the Northern and Southern
Plains regions noted during the study period are
higher than the rates for AI/AN women in other
regions or for NHW women; furthermore, AI/AN
women in general had proportionally more late-stage
diagnoses. For these reasons, additional steps must
be taken to decrease further the rates in AI/AN
women. Because smoking is an independent risk fac-
tor for cervical cancer, tobacco use prevention efforts
among AI/AN populations is essential, in addition to
increasing the uptake of screening among AI/AN
women. Although the HPV vaccine may have an
effect in rate reduction in future generations, aggres-
sive screening programs must remain in place. Vigi-
lance concerning screening on the part of clinicians
and their AI/AN patients clearly remains an impor-
tant approach to cervical cancer control. For more
information about cervical cancer, please visit
www.cdc.gov/cancer/gynecologic.
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